Explore Watchlists Pricing

JCR Pharmaceuticals Co.,Ltd. (4552) Balance sheet

Market cap

¥60.4B

P/E ratio

284.2x

JCR Pharma develops and manufactures pharmaceutical and regenerative medicine products for healthcare providers worldwide, with specialized focus on advanced regenerative treatments.

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03	2026/03
Cash and cash equivalents	-	1,137	1,949	5,509	4,895	7,836	10,973	26,260	30,733	13,278	18,756	13,196	14,007
Marketable securities, current	-	3,736	1,927	300	1,217	661	220	-	244	-	-	-	-
Accounts receivable, net	-	5,204	5,384	5,435	7,103	8,835	7,977	8,183	15,585	-	-	-	-
Inventories	-	1,523	1,582	1,757	1,759	2,281	880	1,367	2,121	1,098	2,111	2,571	2,117
Total current assets	-	17,191	18,366	20,315	23,327	27,368	28,342	48,545	62,188	47,802	57,581	51,056	56,076
Property, plant and equipment, net	-	11,612	11,445	11,388	10,853	11,061	14,875	17,172	26,782	32,681	30,040	37,410	39,244
Marketable securities, non-current	-	3,891	4,248	3,588	3,194	2,941	2,408	2,572	2,230	8,867	9,120	9,629	7,833
Total non-current assets	-	16,895	16,981	16,070	15,070	15,147	19,433	25,238	34,946	47,135	44,644	53,798	53,160
Total assets	-	34,086	35,347	36,385	38,398	42,516	47,775	73,784	97,134	94,937	102,226	104,855	109,236
Accounts payable	-	534	783	700	585	586	679	2,932	1,324	-	-	-	-
Short-term debt	-	1,950	1,760	1,494	2,893	3,630	4,880	12,850	15,150	16,800	8,950	23,005	38,092
Long-term debt, current	-	740	-	-	-	-	-	-	-	-	750	3,050	3,600
Total current liabilities	-	5,135	6,067	4,707	7,105	8,684	10,434	29,028	42,054	35,762	30,135	43,988	48,135
Total non-current liabilities	-	2,686	2,217	4,092	3,764	2,957	4,761	6,199	3,990	6,761	15,615	13,431	13,741
Total liabilities	-	7,821	8,284	8,799	10,870	11,642	15,195	35,227	46,045	42,523	45,750	57,420	61,877
Retained earnings	-	5,780	6,930	8,149	10,469	13,350	15,039	20,904	33,241	34,273	37,278	31,191	31,226
Stockholders' equity	24,581	26,265	27,063	27,586	27,528	30,874	32,579	38,557	51,089	52,413	56,475	47,435	47,359
Working capital	-									-	-	-	-